BioMark Diagnostics Inc.
BUX
Kedudukan dalam Saham
#26617
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Harga Saham
$0.34495034
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$36.73M
Perubahan (1 hari)
-4.08%
Perubahan (1 tahun)
53.78%
Negara
CA
Perdagangan BioMark Diagnostics Inc. (BUX)
Kategori
Healthcare
Sejarah hasil dividen untuk BioMark Diagnostics Inc. (BUX)
Hasil dividen (TTM) bagi BioMark Diagnostics Inc. (simbol saham: BUX) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk BioMark Diagnostics Inc. (BUX) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Ubah |
|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | ||
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
| Syarikat | Hasil Dividen | Negara |
|---|---|---|
| 0.27% |
US
|
|
| 0.68% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
CN
|
|
| 0.59% |
US
|
